TY  - GEN
AU  - Llorenç,Victor
AU  - Cordero-Coma,Miguel
AU  - Blanco-Esteban,Ana
AU  - Heras-Mulero,Henar
AU  - Losada-Castillo,María-José
AU  - Jovani-Casano,Vega
AU  - Valls-Pascual,Elia
AU  - Jodar-Marquez,Margarita
AU  - García-Aparicio,Ángel
AU  - Fonollosa,Alejandro
AU  - González-Guijarro,Juan Jacobo
AU  - Rodriguez-Melian,Luís
AU  - Fernández-Prada,Manuel
AU  - Jerez-Fidalgo,María
AU  - Hernandez-Garfella,Marisa
AU  - Esquinas,Cristina
AU  - Sainz-de-la-Maza,Maite
AU  - Adán,Alfredo
TI  - Drug Retention Rate and Causes of Discontinuation of Adalimumab in Uveitis: Real-World Data from the Biotherapies in Uveitis (BioÚvea) Study Group
SN  - 1549-4713
PY  - 2020///1211
KW  - Adalimumab
KW  - adverse effects
KW  - Adult
KW  - Anti-Inflammatory Agents
KW  - Biological Therapy
KW  - Drug-Related Side Effects and Adverse Reactions
KW  - diagnosis
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Proportional Hazards Models
KW  - Registries
KW  - statistics & numerical data
KW  - Retrospective Studies
KW  - Spain
KW  - Uveitis
KW  - Withholding Treatment
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.ophtha.2019.11.024
ER  -